CAS No.136572-09-3 Pharmaceutical Intermediates
Product detail
Irinotecan hydrochloride trihydrate is a potent chemotherapeutic agent used primarily in the treatment of colorectal cancer. As a topoisomerase I inhibitor, it interferes with the DNA replication process in cancer cells, leading to cell death. This innovative compound is a water-soluble salt of irinotecan that improves its bioavailability and therapeutic efficacy. Our products are manufactured under strict quality control measures, ensuring compliance with the highest industry standards.
product detail
|
CAS No. |
40856-44-8 |
|
EINECS |
609-874-3 |
|
Formula |
C9H11NO2 |
|
Molecular Weight |
165.19 |
|
Appearance |
White to Off-White solid |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
Irinotecan hydrochloride trihydrate is widely used in the pharmaceutical industry to treat various cancers, especially colorectal cancer. Its application extends to combination therapy, often with other chemotherapy drugs to enhance the therapeutic effect. The compound is also being studied for the treatment of other malignancies, demonstrating its versatility and importance in oncology.
In summary, Irinotecan hydrochloride trihydrate is an important pharmaceutical product that plays a vital role in cancer treatment. With its superior physical and chemical properties, proven efficacy, and commitment to quality, our products stand out in the competitive pharmaceutical landscape. Partner with us for your Irinotecan hydrochloride trihydrate needs and experience the benefits of working with a trusted manufacturer committed to excellence in the pharmaceutical industry. Contact us today to learn more about our products and how we can support your business.



